Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Nuvation Bio Inc.
Exelixis
Tango Therapeutics, Inc.
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
AstraZeneca